GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 41 filers reported holding GALERA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $293,822 | -94.4% | 1,678,984 | 0.0% | 0.00% | -95.5% |
Q2 2023 | $5,238,430 | +21.9% | 1,678,984 | 0.0% | 0.02% | +22.2% |
Q1 2023 | $4,298,199 | +71.8% | 1,678,984 | 0.0% | 0.02% | +100.0% |
Q4 2022 | $2,501,686 | +85544.8% | 1,678,984 | 0.0% | 0.01% | -18.2% |
Q3 2022 | $2,921 | -99.9% | 1,678,984 | 0.0% | 0.01% | +57.1% |
Q2 2022 | $2,183,000 | -45.4% | 1,678,984 | 0.0% | 0.01% | -30.0% |
Q1 2022 | $3,996,000 | -48.2% | 1,678,984 | 0.0% | 0.01% | -47.4% |
Q4 2021 | $7,707,000 | -43.3% | 1,678,984 | 0.0% | 0.02% | -36.7% |
Q3 2021 | $13,600,000 | -17.6% | 1,678,984 | 0.0% | 0.03% | -18.9% |
Q2 2021 | $16,504,000 | +11.4% | 1,678,984 | 0.0% | 0.04% | +23.3% |
Q1 2021 | $14,809,000 | -13.8% | 1,678,984 | 0.0% | 0.03% | -50.0% |
Q4 2020 | $17,176,000 | +13.2% | 1,678,984 | 0.0% | 0.06% | +1.7% |
Q3 2020 | $15,178,000 | +26.6% | 1,678,984 | 0.0% | 0.06% | +15.7% |
Q2 2020 | $11,988,000 | -24.8% | 1,678,984 | 0.0% | 0.05% | -56.0% |
Q1 2020 | $15,950,000 | -27.8% | 1,678,984 | 0.0% | 0.12% | -19.4% |
Q4 2019 | $22,095,000 | – | 1,678,984 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nan Fung Group Holdings Ltd | 613,223 | $2,815,000 | 0.83% |
Sofinnova Investments, Inc. | 3,083,712 | $14,154,000 | 0.83% |
Novo Holdings A/S | 2,459,021 | $11,287,000 | 0.53% |
ACUTA CAPITAL PARTNERS, LLC | 262,500 | $1,205,000 | 0.51% |
Tekla Capital Management LLC | 898,374 | $4,124,000 | 0.13% |
Aristides Capital LLC | 20,000 | $92,000 | 0.04% |
XTX Topco Ltd | 13,499 | $62,000 | 0.04% |
Blackstone Inc. | 1,678,984 | $7,707,000 | 0.02% |
Taylor Wealth Management Partners | 11,635 | $53,000 | 0.02% |
Belvedere Trading LLC | 96,486 | $255,000 | 0.01% |